Patent · US Active

Treatment of uveitis

US8968731B2 · kind B2 · utility

1Cited by

3References

8Claims

0Family size

Assignee

CSL LIMITED · AU

Inventors

Ian Wicks · Melbourne, AU
Ian Keith Campbell · Melbourne, AU
Ann Leckie Cornish · Melbourne, AU

Key dates

Filing date	Oct 8, 2010
Grant date	Mar 3, 2015
Priority date	—
Expiry date	Oct 14, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates generally to the use of antagonists of G-CSF, and/or its receptor (G-CSFR) in the treatment of uveitis. The present invention contemplates, therefore, the inhibition of G-CSF or G-CSFR systemically or locally and/or the down-regulation of expression of a G-CSF or G-CSFR in the treatment of uveitis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.